Multiple studies have demonstrated that the TLR4/NF-κB signaling pathway crucially facilitates the activation of neuroinflammation secondary to stroke [47,48,49], and there is evidence showing that inhibiting TLR4/NF-κB pathway activation can reduce cerebral edema and the infarct volume in rats with MCAO [50]. Here, NFKB1 is linked to stroke disorder.